Tumour‐associated macrophages act as a slow‐release reservoir of nano‐therapeutic Pt(IV) pro‐drug
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Therapeutic nanoparticles (TNPs) aim to deliver drugs more safely and effectively to cancers, yet clinical results have been unpredictable owing to limited in vivo understanding. Here we use single-cell imaging of intratumoral TNP pharmacokinetics and pharmacodynamics to better comprehend their heterogeneous behaviour. Model TNPs comprising a fluorescent platinum(IV) pro-drug and a clinically tested polymer platform (PLGA-b-PEG) promote long drug circulation and alter accumulation by directing cellular uptake toward tumour-associated macrophages (TAMs). Simultaneous imaging of TNP vehicle, its drug payload and single-cell DNA damage response reveals that TAMs serve as a local drug depot that accumulates significant vehicle from which DNA-damaging Pt payload gradually releases to neighbouring tumour cells. Correspondingly, TAM depletion reduces intratumoral TNP accumulation and efficacy. Thus, nanotherapeutics co-opt TAMs for drug delivery, which has implications for TNP design and for selecting patients into trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Miller et al. found a reduction in liver metastases due to enhanced delivery of nano‐encapsulated platinum in the TME via TAMs in a breast cancer mouse model [87].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
A global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491
The Chemistry of Fluorescent Bodipy Dyes: Versatility Unsurpassed
Ulrich, G., Ziessel, R., & Harriman, A. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200702070 · Cited by 3,161
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Self-citationMacrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Cited by
Items 201–300 of 448
Rational nanocarrier design towards clinical translation of cancer nanotherapy
Guo, D., Ji, X., & Luo, J. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe35a · Cited by 40
“The intrinsic physiological barriers of the tumormicroenvironment, including dense interstitial matrix, high IFP and dysfunctional lymphatics deep in the tumor, resulting in less transportation of NPs into the interstitial space, and nonspecific uptake of perivascular stromal cells [96, 97].”
BackgroundHuang, S., Xu, D., Zhang, L., Liang, H., Jia, Y., Zhang, X., Cheng, T., & Chen, J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106778 · Cited by 39
Application of Nanomaterial-Based Sonodynamic Therapy in Tumor Therapy
Yang, N., Li, J., Yu, S., Xia, G., Li, D., Yuan, L., Wang, Q., Ding, L., Fan, Z., & Li, J. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050603 · Cited by 44
“TAM plays a crucial role in the TME, influencing the uptake and distribution of tumor NPs [120].”
BackgroundHarnessing Macrophages for Controlled-Release Drug Delivery: Lessons From Microbes
Visser, J. G., Staden, A. D. P. V., & Smith, C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00022 · Cited by 42
Bera, A., Gautam, S., Raza, M. K., Kondaiah, P., & Chakravarty, A. R. (2021) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2021.111526 · Cited by 38
Napp, J., Markus, M. A., Heck, J. G., Dullin, C., Möbius, W., Gorpas, D. S., Feldmann, C., & Alves, F. (2018) · Theranostics · doi:10.7150/thno.28324 · Cited by 39
“TAMs were suggested to serve as a local drug depot that accumulates significant vehicle from which the drug payload gradually releases to neighbouring tumour cells [43].”
BackgroundDesign, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles
Rijcken, C. J. F., Lorenzi, F. D., Biancacci, I., Hanssen, R., Thewissen, M. M., Hu, Q., Atrafi, F., Liskamp, R. M. J., Mathijssen, R. H. J., Miedema, I. H. C., et al. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114613 · Cited by 39
Optical and Magnetic Resonance Imaging Using Fluorous Colloidal Nanoparticles
Wallat, J. D., Czapar, A. E., Wang, C., Wen, A. M., Wek, K. S., Yu, X., Steinmetz, N. F., & Pokorski, J. K. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.6b01389 · Cited by 36
Chen, H., Chen, F., Hu, W., & Gou, S. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.11.017 · Cited by 37
Nanotechnology-based delivery systems to overcome drug resistance in cancer
Patel, H. H., Li, J., Bo, L., Mehta, R., Ashby, C. R., Wang, S., Cai, W., & Chen, Z. (2024) · Medical Review · doi:10.1515/mr-2023-0058 · Cited by 45
Use of Nanoformulation to Target Macrophages for Disease Treatment
Liu, X., Xie, X., Jiang, J., Lin, M. J., Zheng, E., Qiu, W., Yeung, I., Zhu, M., Li, Q., Xia, T., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202104487 · Cited by 38
Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics
Sarkar, M., Wang, Y., Ekpenyong, O., Liang, D., & Xie, H. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1846 · Cited by 45
Near-Infrared Polymer Dots with Aggregation-Induced Emission for Tumor Imaging
Zhang, Z., Chen, D., Liu, Z., Wang, D., Guo, J., Zheng, J., Qin, W., & Wu, C. (2020) · ACS Applied Polymer Materials · doi:10.1021/acsapm.9b00977 · Cited by 35
Screening for new macrophage therapeutics
Rodell, C. B., Koch, P. D., & Weissleder, R. (2019) · Theranostics · doi:10.7150/thno.34421 · Cited by 35
Self-citationZhao, R., Cao, J., Yang, X., Zhang, Q., Iqbal, M. Z., Lü, J., & Kong, X. (2021) · Biomaterials Science · doi:10.1039/d1bm00508a · Cited by 36
Remodeling tumor microenvironment with nanomedicines
Martin, J. D., Miyazaki, T., & Cabral, H. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1730 · Cited by 42
Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma
Roberts, N. B., Wadajkar, A. S., Winkles, J. A., Dávila, E., Kim, A. J., & Woodworth, G. F. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1208876 · Cited by 36
Vakili‐Ghartavol, R., Mombeiny, R., Salmaninejad, A., Rezayat, S. M., Majidi, R. F., Jaafari, M. R., & Mirzaei, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27027 · Cited by 35
“For instance, a recent study has reported that TAMs act as a local reservoir for therapeutic nanoparticles involving platinum (IV) that accumulates significant transporters in which platinum (IV) gradually gets released to the neighboring tumor cells (Miller et al., 2015).”
BackgroundEngineering CpG‐ASO‐Pt‐Loaded Macrophages (CAP@M) for Synergistic Chemo‐/Gene‐/Immuno‐Therapy
Wang, Y., Zhang, L., Liu, Y., Tang, L., He, J., Sun, X., Younis, M. H., Cui, D., Xiao, H., Gao, D. M., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201178 · Cited by 34
Nomani, A., Yousefi, S., Sargsyan, D., & Hatefi, A. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.03.019 · Cited by 34
Active Nano-targeting of Macrophages
Gaspar, N., Zambito, G., Löwik, C. M. W. G., & Mezzanotte, L. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190710114108 · Cited by 33
Optimizing nanoparticle design and surface modification toward clinical translation
Gessner, I. (2021) · MRS Bulletin · doi:10.1557/s43577-021-00132-1 · Cited by 35
Myeloid cell-mediated drug delivery: From nanomedicine to cell therapy
Zhang, F., Xu, Z., & Jolly, K. J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114827 · Cited by 35
Portillo, A. L., Monteiro, J. K., Rojas, E. A. P., Ritchie, T. M., Gillgrass, A. E., & Ashkar, A. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1286750 · Cited by 35
Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy
Wang, S. J., Li, R., Ng, T. S. C., Luthria, G., Oudin, M. J., Prytyskach, M., Köhler, R. H., Weissleder, R., Lauffenburger, D. A., & Miller, M. A. (2020) · Science Advances · doi:10.1126/sciadv.aaz8521 · Cited by 36
“This formulation is similar to those used in recent reports describing high TAM accumulation of nanoparticles and gradual release of the drug payload to neighboring cancer cells (44).”
Self-citationA Supramolecular Nanocarrier for Delivery of Amiodarone Anti-Arrhythmic Therapy to the Heart
Ahmed, M. S., Rodell, C. B., Hulsmans, M., Köhler, R. H., Aguirre, A. D., Nahrendorf, M., & Weissleder, R. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00882 · Cited by 32
Self-citationNg, T. S. C., Gunda, V., Li, R., Prytyskach, M., Iwamoto, Y., Köhler, R. H., Parangi, S., Weissleder, R., & Miller, M. A. (2020) · Radiology · doi:10.1148/radiol.2020201791 · Cited by 35
“TAM can also influence drug accumulation in solid tumors (13), for instance, enabling delivery of clinically relevant model drug delivery nanoparticle system (DDNP) (14), partly through promoting the enhanced permeability and Detecting Immune Response to Therapies Targeting PDL1 and BRAF by Using Ferumoxytol MRI and M…”
BackgroundSelf-citationThe spatiotemporal journey of nanomedicines in solid tumors on their therapeutic efficacy
Qin, M., Xia, H., Xu, W., Chen, B., & Wang, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115137 · Cited by 33
Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment
Harrison, E. B., Azam, S. H., & Pecot, C. V. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00307 · Cited by 33
“Additionally, single cell pharmacokinetics of NPs within tumors has revealed that TAMs can serve as reservoirs for NPs, releasing small molecule drugs (Miller et al., 2015).”
BackgroundMacrophage-mediated cancer drug delivery
Wang, H., Liu, Y., Yang, G., & Zhao, C. (2020) · Materials Today Sustainability · doi:10.1016/j.mtsust.2020.100055 · Cited by 36
Mónaco, A., Chilibroste, S., Yim, L., Chabalgoity, J. A., & Moreno, M. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03148-x · Cited by 35
“The regime consisted of 3 intraperitoneal doses of 700 μg/ml each separated by 5 days as previously described [22] and adapted to our model.”
MethodIntravital microscopy for real-time monitoring of drug delivery and nanobiological processes
Momoh, J., Kapsokalyvas, D., Vogt, M., Hak, S., Kiessling, F., van Zandvoort, M., Lammers, T., & Sofias, A. M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114528 · Cited by 33
Supramolecular platinum complexes for cancer therapy
Jogadi, W., & Zheng, Y. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102276 · Cited by 31
Self-citationOh, N., Kim, Y., Kweon, H., Oh, W., & Park, J. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b10302 · Cited by 30
Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment
Atkinson, S. P., Andreu, Z., & Vicent, M. J. (2018) · Journal of Personalized Medicine · doi:10.3390/jpm8010006 · Cited by 32
“Another important component of the TME are TAMs, which have been described as reservoirs that gradually release their “payload” to neighboring tumor cells [114].”
Backgroundde Lázaro, I., Sharp, P. S., Gürcan, C., Ceylan, A., Stylianou, M., Kisby, T., Chen, Y., Vranic, S., Barr, K., Taheri, H., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000109 · Cited by 31
Modulation of actin dynamics as potential macrophage subtype-targeting anti-tumour strategy
Pergola, C., Schubert, K., Pace, S., Ziereisen, J., Nikels, F., Scherer, O., Hüttel, S., Zahler, S., Vollmar, A. M., Weinigel, C., et al. (2017) · Scientific Reports · doi:10.1038/srep41434 · Cited by 29
Prabhu, S., Deng, H., Cross, T.-W., Shahoei, S. H., Konopka, C. J., Medina, N. G., Applegate, C. C., Wallig, M. A., Dobrucki, L. W., Nelson, E. R., et al. (2021) · Biomaterials Science · doi:10.1039/d0bm01142h · Cited by 31
Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy
Ding, X., Sun, X., Cai, H., Wu, L., Liu, Y., Zhao, Y., Zhou, D., Yu, G., & Zhou, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.786913 · Cited by 30
“In addition, macrophages showed higher drug release efficiency for polymeric or negatively charged copolymerNPs than for liposomalNPsor positively charged copolymer NPs (121, 148, 149).”
BackgroundBruna, F., & Scodeller, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.675664 · Cited by 27
“(93) showed that TAMs slowly released a platinum pro-drug encapsulated in polymeric nanoparticles, acting as slow release drug depots in the tumor.”
BackgroundIslam, M. R., Patel, J., Back, P. I., Shmeeda, H., Adamsky, K., Yang, H., Alvarez, C., Gabizón, A., & La-Beck, N. M. (2022) · Nanotheranostics · doi:10.7150/ntno.75045 · Cited by 29
“Miller and colleagues reported that a PLGA-PEG based polymeric nanoparticle platform directed cellular uptake toward TAM and that TAM served as a reservoir for drug release to local tumor cells [50].”
BackgroundNanoparticle Uptake in a Spontaneous and Immunocompetent Woodchuck Liver Cancer Model
Liu, L. Y., Ma, X., Ouyang, B., Ings, D. P., Marwah, S., Liu, J., Chen, A. Y., Gupta, R., Manuel, J., Chen, X., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c00468 · Cited by 28
UCNP-based Photoluminescent Nanomedicines for Targeted Imaging and Theranostics of Cancer
Guryev, E. L., Smyshlyaeva, A. S., Shilyagina, N. Y., Соколова, Е. А., Shanwar, S., Kostyuk, A. B., Lyubeshkin, A. V., Schulga, A. A., Коновалова, Е. В., Lin, Q., et al. (2020) · Molecules · doi:10.3390/molecules25184302 · Cited by 27
“Macrophages located in the tumor are also able to accumulate such substances, thereby increasing their retention time [16].”
BackgroundRevisiting the outstanding questions in cancer nanomedicine with a future outlook
Sudheesh, M. S., Pavithran, K., & Sabitha, M. (2021) · Nanoscale Advances · doi:10.1039/d1na00810b · Cited by 27
Softness‐Aided Mild Hyperthermia Boosts Stiff Nanomedicine by Regulating Tumor Mechanics
Li, Z., Zhu, Y., Zhang, Z., Wang, H., Wang, C., Chen, X., Li, S., Zhang, S., Yang, X., & Li, Z. (2024) · Advanced Science · doi:10.1002/advs.202306730 · Cited by 37
Measurement of drug-target engagement in live cells by two-photon fluorescence anisotropy imaging
Vinegoni, C., Feruglio, P. F., Brand, C., Lee, S., Nibbs, A. E., Stapleton, S., Shah, S., Gryczyński, I., Reiner, T., Mazitschek, R., et al. (2017) · Nature Protocols · doi:10.1038/nprot.2017.043 · Cited by 29
Self-citationWang, J., Zhang, Y., Zhang, G., Li, X., Pang, H., Xiong, K., Lü, Y., Li, J., Dai, J., Lin, S., et al. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2036871 · Cited by 26
“In addition, the disruption of tumor microvessels also releases the tumor-associated macrophages (TAMs), which then infiltrate into the tumor tissue and further enhance nano-drug accumulation (Miller et al., 2015).”
BackgroundStrittmatter, N., Moss, J. I., Race, A. M., Sutton, D., Canales, J. R., Ling, S., Wong, E., Wilson, J., Smith, A., Howes, C., et al. (2022) · Theranostics · doi:10.7150/thno.68000 · Cited by 25
“Some studies report that NPs are preferentially taken up by immune cells in the TME which can then act as drug depots [42, 43].”
BackgroundMethodInfluentialTargeting metastasis with nanomedicine
Pallares, R. M., Consolino, L., Wang, A., Lorenzi, F. D., Kiessling, F. M., Schroeder, A., & Lammers, T. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00358-7 · Cited by 29
Niu, B., Wu, Y., Zhou, M., Lin, R., Ge, P., Chen, X., Zhou, H., Zhang, X.-K., & Xie, J. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216461 · Cited by 25
Zhao, Y., Zhang, C., Gao, L., Yu, X., Lai, J., Lu, D., Bao, R., Wang, Y., Jia, B., Wang, F., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1655 · Cited by 27
“Macrophages in the tumor microenvironment engulf nanoparticles by phagocytosis (23,24) and promote tumor uptake, thereby increasing the efficacy of drugs delivered by nanoparticles (25,26).”
BackgroundInfluentialImmunostimulatory biomaterials to boost tumor immunogenicity
Shofolawe-Bakare, O. T., Stokes, L. D., Hossain, M., Smith, A. E., & Werfel, T. A. (2020) · Biomaterials Science · doi:10.1039/d0bm01183e · Cited by 24
Liu, K., Xiang, J., Wang, G., Xu, H., Piao, Y., Liu, X., Tang, J., Shen, Y., & Zhou, Z. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c12156 · Cited by 24
Stilgenbauer, M., Jayawardhana, A. M. D. S., Datta, P., Yue, Z., Gray, M., Nielsen, F., Bowers, D. J., Xiao, H., & Zheng, Y. (2019) · Chemical Communications · doi:10.1039/c9cc02081k · Cited by 24
Self-citationSu, C., Liu, S., Cao, S., Yin, S., Zhou, C., Gao, S., Jia, C., Ji, Y., & Liu, Y. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00725-z · Cited by 24
“Nanotechnology is an emerging technology, and due to its good biocompatibility[13, 14], moderate delivery e ciency[15, 16], and outstanding sustained release performance[17, 18] and stability, it has been widely applied in energy conversion and storage[19, 20], microelectronics[21], precision biology[22, 23], environm…”
BackgroundMaliyakkal, N., Beeran, A. A., & Udupa, N. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.07.001 · Cited by 24
“Similarly, platinum prodrug-PLGA-PEG NPs caused enhanced drug accumulations in tumor-associated macrophages with controlled drug release effects in tumor cells (Miller et al., 2015).”
Wang, Y., Guo, G., Feng, Y., Long, H., Ma, D., Leung, C., Dong, L., & Wang, C. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01495c · Cited by 23
Luthria, G., Li, R., Wang, S., Prytyskach, M., Köhler, R. H., Lauffenburger, D. A., Mitchison, T. J., Weissleder, R., & Miller, M. A. (2020) · Nature Communications · doi:10.1038/s41467-020-17147-y · Cited by 25
Self-citationLi, B., Chu, F., Lu, Q., Wang, Y., & Lane, L. A. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.11.047 · Cited by 23
Addressing the in vivo delivery of nucleic-acid nanostructure therapeutics
Alexander, S., Moghadam, M. G., Rothenbroker, M., & Chou, L. Y. T. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114898 · Cited by 25
Fu, Y., Kong, Y., Li, X., Cheng, D., Hou, Y., Li, Y., Li, T., Xiao, Y., Zhang, Q., & Rong, R. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2171158 · Cited by 23
“Although this multistep process is important for overall therapeutic outcomes, little experimental investigation exists that interprets how this multi-step process carry out in vivo (Miller et al., 2015).”
BackgroundShukla, S., Dorand, R. D., Myers, J., Woods, S. E., Gulati, N. M., Stewart, P. L., Commandeur, U., Huang, A. Y.-C., & Steinmetz, N. F. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00060 · Cited by 23
Shi, J., Ma, W., Deng, J., Zheng, S., Xia, F., Liu, X., Kikkawa, A., Tanaka, K., Kamei, K., & Tian, C. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122489 · Cited by 21
Theranostic nanomedicine by surface nanopore engineering
Li, Z., Yu, L., Yang, T., & Chen, Y. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9297-5 · Cited by 21
Nanoparticle-mediated local delivery of pioglitazone attenuates bleomycin-induced skin fibrosis
Kanemaru, M., Asai, J., Jo, J., Arita, T., 美奈子, 河., Tsutsumi, M., Wada, M., Tabata, Y., & Katoh, N. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.11.012 · Cited by 23
Koch, P. D., Rodell, C. B., Köhler, R. H., Pittet, M. J., & Weissleder, R. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2019.12.007 · Cited by 22
“While not explored in this research, complexing LCL161 to a CDNP should result in some delivery to tumor cells, as through local release from immune cells(Miller et al., 2015) leading to apoptosis of cancer cells.”
BackgroundSelf-citationGrigoletto, A., Tedeschini, T., Canato, E., & Pasut, G. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1689 · Cited by 25
A review: potential application and outlook of photothermal therapy in oral cancer treatment
Cao, L., Wu, Y., Shan, Y., Tan, B., & Liao, J. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac5a23 · Cited by 22
Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment
Essa, N., O’Connell, F., Prina‐Mello, A., O'Sullivan, J. N., & Marcone, S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.017 · Cited by 21
Liu, X.-M., Zhu, Z., He, X., Zou, Y., Chen, Q., Wang, X., Liu, H., Qiao, X., Wang, X., & Xu, J. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c08899 · Cited by 20
Ge, D., Ma, S., Sun, T., Li, Y., Wei, J., Wang, C., Chen, X. S., & Liao, Y. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122955 · Cited by 20
Yao, X., Zhu, Q., Li, C., Yuan, K., Che, R., Zhang, P., Yang, C., Lu, W. P., Wu, W., & Jiang, X. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb02863b · Cited by 20
Benchimol, M. J., Bourne, D. W. A., Moghimi, S. M., & Simberg, D. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1566339 · Cited by 20
“unevenly distributed throughout the tumour [56].”
NF-κB hijacking theranostic Pt(ll) complex in cancer therapy
Zhu, Y., Zhang, M., Luo, L., Gill, M. R., Pace, C. D., Battaglia, G., Zhang, Q., Zhou, H., Wu, J., Tian, Y., et al. (2019) · Theranostics · doi:10.7150/thno.30886 · Cited by 22
“Researchers have found that functionalized nanoparticles could favour platinum complexes to deliver in place, as well as avoiding side-effect to certain degree [12-15].”
BackgroundDarguzyte, M., Holm, R., Baier, J., Drude, N., Schultze, J., Koynov, K., Schwiertz, D., Dadfar, S. M., Lammers, T., Barz, M., et al. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00593 · Cited by 23
Progress in Tumor‐Associated Macrophages: From Bench to Bedside
Wang, Y., Lin, Y., Qiao, S., Wang, J., & Wang, H. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800232 · Cited by 21
Surface-Modified Macrophages Facilitate Tracking of Breast Cancer-Immune Interactions
Joshi, B. P., Hardie, J. M., Mingroni, M. A., & Farkas, M. E. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00509 · Cited by 20
Naumenko, V., Vodopyanov, S., Vlasova, K. Y., Potashnikova, D. M., Melnikov, P., Vishnevskiy, D. A., Garanina, A. S., Valikhov, M. P., Lipatova, A. V., Chekhonin, V. P., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.014 · Cited by 21
Aliphatic Polyester‐Based Materials for Enhanced Cancer Immunotherapy
Chin, A. L., Wang, X., & Tong, R. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100087 · Cited by 19
Novel Anthracycline Utorubicin for Cancer Therapy
Simón‐Gracia, L., Sidorenko, V., Uustare, A., Ogibalov, I., Tasa, A., Tšubrik, O., & Teesalu, T. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202016421 · Cited by 20
Passeri, G., Northcote‐Smith, J., & Suntharalingam, K. (2022) · RSC Advances · doi:10.1039/d1ra08788f · Cited by 19
Advanced optical imaging for the rational design of nanomedicines
Ortiz‐Perez, A., Zhang, M., Fitzpatrick, L. W., Izquierdo-Lozano, C., & Albertazzi, L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115138 · Cited by 19
Wu, Y.-G., Wang, D.-B., Hu, J., Song, X., Xie, C., Ma, Z., & Xu, J. (2019) · Inorganic Chemistry Frontiers · doi:10.1039/c9qi00030e · Cited by 19
Understanding the In Vivo Fate of Advanced Materials by Imaging
Li, R., Ng, T. S. C., Garlin, M. A., Weissleder, R., & Miller, M. A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910369 · Cited by 20
Self-citationRyu, S., Ohuchi, M., Yagishita, S., Shimoi, T., Yonemori, K., Tamura, K., Fujiwara, Y., & Hamada, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-72665-5 · Cited by 22
M1 Macrophage-Derived Sonoresponsive Nanoparticles for Sonodynamic Anticancer Therapy
Chen, S., Wang, J., Liao, H., Tang, K., Xu, Y., Wang, L., & Niu, C. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s381170 · Cited by 20
“Tumor-associated macrophages in the tumor microenvironment have been found to play an important role in determining tumor nanoparticle uptake and intratumoral distribution.(18) Different subsets of tumor-associated macrophages may play different roles in tumor development.”
BackgroundBecker, S., Momoh, J., Biancacci, I., Möckel, D., Wang, Q., May, J., Su, H., Candels, L. S., Berres, M., Kiessling, F. M., et al. (2023) · Small · doi:10.1002/smll.202208042 · Cited by 17
Ding, Z., Wei, K., Zhang, Y., Ma, X., Yang, L., Zhang, W., Liu, H., Jia, C., Shen, W., Ma, S., et al. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01270 · Cited by 17
Sustained and Localized Drug Depot Release Using Radiation‐Activated Scintillating Nanoparticles
Kang, M., Quintana, J. M., Hu, H., Teixeira, V. C., Olberg, S., Banla, L. I., Rodriguez, V. E., Hwang, W. L., Schuemann, J., Parangi, S., et al. (2024) · Advanced Materials · doi:10.1002/adma.202312326 · Cited by 18
Self-citationMuteeb, G., Khafaga, D. S. R., El-Morsy, M. T., Farhan, M., Aatif, M., & Hosney, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37217 · Cited by 17
“Notably, tumor macrophage uptake of nanoparticles is critical to generating therapeutically beneficial drug accumulation within tumors, as the elimination of macrophages significantly reduces nanoparticle deposition and renders the treatment ineffective [115].”
BackgroundSingle‐Cell Intravital Microscopy of Trastuzumab Quantifies Heterogeneous in vivo Kinetics
Li, R., Atari, A., Prytyskach, M., Garlin, M. A., Weissleder, R., & Miller, M. A. (2019) · Cytometry Part A · doi:10.1002/cyto.a.23872 · Cited by 18
“IVM has visualized drug payload in these nanoparticles as slowly leaching out of the macrophages and transferring to surrounding cancer cells (29).”
BackgroundMethodSelf-citationAdvances and Challenges of Nanoparticle-Based Macrophage Reprogramming for Cancer Immunotherapy
Kapitanova, K., Naumenko, V., Garanina, A. S., Melnikov, P., Abakumov, M. A., & Alieva, I. B. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919070058 · Cited by 19
Photoactivated Lysosomal Escape of a Monofunctional PtII Complex Pt‐BDPA for Nucleus Access
Xue, X., Qian, C., Fang, H., Liu, H., Yuan, H., Guo, Z., Bai, Y., & He, W. (2019) · Angewandte Chemie · doi:10.1002/ange.201906203 · Cited by 19
Macrophage-Based Microrobots for Anticancer Therapy: Recent Progress and Future Perspectives
Nguyen, V. D., Park, J., & Choi, E. (2023) · Biomimetics · doi:10.3390/biomimetics8070553 · Cited by 16
“In a study by Weissleder et al., nanotherapeutics consisting of fluorescent platinum (IV) pro-drugs and a clinically tested polymer platform (PLGA-b-PEG) were slowly released from tumor-associated macrophages when infused into mice [93].”
BackgroundNanotherapeutics for Macrophage Network Modulation in Tumor Microenvironments: Targets and Tools
Li, R., Huang, J., Wei, Y., Wang, Y., Lu, C., Liu, J., & Ma, X. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s491573 · Cited by 19
Wang, F., Wang, X., Gao, L., Meng, L.-Y., Xie, J.-M., Xiong, J., & Luo, Y. (2019) · Nanoscale · doi:10.1039/c9nr05758g · Cited by 18
Sofias, A. M., Bjørkøy, G., Ochando, J., Sønstevold, L., Hegvik, M., Davies, C. D. L., Haraldseth, O., Lammers, T., Mulder, W. J. M., & Hak, S. (2021) · Advanced Science · doi:10.1002/advs.202100370 · Cited by 18
Lorenzi, F. D., Rizzo, L. Y., Daware, R., Motta, A., Baues, M., Bartneck, M., Vogt, M., van Zandvoort, M. A. M. J., Kaps, L., Hu, Q., et al. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01204-8 · Cited by 16
“Furthermore, the retention of nanomedicines at malignant sites has been described to be secondary to phagocytic uptake by tumorassociated macrophages (TAMs) as a mechanism of nanoparticle retention [15].”
BackgroundRadiation-assisted strategies provide new perspectives to improve the nanoparticle delivery to tumor
Zhang, D., He, J., & Zhou, M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114642 · Cited by 18
Bajgar, A., Saloň, I., Krejčová, G., Doležal, T., Jindra, M., & Štĕpánek, F. (2019) · Biomaterials Science · doi:10.1039/c9bm00539k · Cited by 16
Metadata
- Authors
- Miller, M. A., Zheng, Y.-R., Gadde, S., Pfirschke, C., Zope, H., Engblom, C., Kohler, R. H., Iwamoto, Y., Yang, K. S., Askevold, B., Kolishetti, N., Pittet, M., Lippard, S. J., Farokhzad, O. C., & Weissleder, R.
- Affiliations
- Harvard University (US)
- Massachusetts Institute of Technology (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weissleder, Ralph
- ORCID
- Venue
- Nature Communications
- Published
- 2015-10-27
- Volume
- 6
- Issue
- 1
- Pages
- 8692-8692
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4711745
- OpenAlex
- W1874889006
- Cited by
- 441
- References
- 70
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 38 · 2023: 40 · 2022: 40 · 2021: 46 · 2020: 62 · 2019: 55 · 2018: 48 · 2017: 42 · 2016: 23
- FWCI
- 13.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- Deutsche Forschungsgemeinschaft (PF809/1-1, CA034992)
- National Institutes of Health (CA151884, U54-CA151884, CA034992, CA139980, PO1-CA139980)
- National Cancer Institute (CA-034992, CA139980, P50CA086355, R01CA164448, U54CA151884, P01CA139980, R37CA034992, CA151884, R01CA034992, P30CA014051, T32CA079443)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- tumour-associated macrophages, nanotherapeutics, pharmacodynamics, single-cell imaging, DNA damage response, slow drug release, TAM depletion, nanoparticle accumulation, cancer nanomedicine
- MeSH terms
- Animals, Antineoplastic Agents, Female, Humans, Macrophages, Mice, Inbred C57BL, Mice, Nude, Neoplasms, Platinum, Prodrugs, Drug Delivery Systems, Cell Line, Tumor, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.